Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BAM ! 1,000,000 are already past again...
Vol 1,000,000 ahead ! Gigantic and impressive. Geez, that will be fun.
...and who sold today will not take part in it.
$9 cracked, today is the day ?
$$$$
$ 8.19 pre ? Woohoo !
Maybe we should see the $10 today ? And tomorrow ? This could be something huge again.
$7.49 pre
Today $8 and tomorrow $10 ? What about weekend ? More $ NEWS $ ahead ?
Pre-market going up up up already !
News $ News $ News $ News
Arcadia Biosciences, a Leader in Advanced Agricultural Breeding and Gene Optimization, Announces New Business Unit Dedicated to Cannabis
RKDA: New Business Unit Dedicated to Cannabis
Arcadia Specialty Genomics to bring standardization and optimization to America’s cannabis crop with a focus on improved plant quality, resiliency and yield.
Geeez ! Large amounts of additional income $$$ besides newer wheat developments !
Squeeeeeze it
Who's missing something now ? Me not. Look at the chart. ROFL.
HyperSolar’s goals for 2018 are clear
Means more time to wait till 2019 ! I sell my stuff at .011 down to 8 cause I bought between 6 an 7.
I did not beg for money, they'll give it freely. Geez. That must be fun.
The germans did not catch it, yet ? Don't they know what's ahead ?
Buying at Frankfort Stock Exchange ? No, wait, it's Berlin Stock Exchange !
Already found the next great chance. Look ahead!
Hope, you found it. Look now ! Big gainer in my pockets. My new car is paid for sure. Woohoo!
Profit 2018 could be vast then ! FDA FAST TRACK for f(v)ast tracks. Geez! That must be fun.
Read more, soon.
$SGBI - FDA GRANTS FAST TRACK DESIGNATION TO GRANULOX
FDA FAST Track Designation
FDA grants FAST TRACK DESIGNATION
Witten, November, 13, 2017: Infirst Healthcare Ltd has announced that the United States (US) Food and Drug Administration (FDA) has granted Fast Track designation to Granulox 10% haemoglobin spray (porcine haemoglobin) for the treatment of diabetic foot ulcers (DFUs). It is the first and only haemoglobin spray to receive Fast Track designation – a process designed by the FDA to facilitate the development, and expedite the review of, new therapies to treat serious conditions and fill an unmet medical need.
Wowsers! $$$ Big gainer this one! $$$ GLTA
New private placement fully subscribed !
Private Placement closed
RELEASE SOON ! CannaLife Blockchain&Artificial Intelligent - Social Engagement App for Medical Cannabis
Announces CannaLife App on Google Play
In a hurry. Must catch my train to Columbus...look at sedar.com. Search database...you'll find everything there. ryl.
Over 25 million shares traded on TSXV since the beginning of july 2017. That's only 3 month !! And prices were calmed down since then.
$$$ Big Gainer ahead ? $$$
WHO owns all that papers ? This question has prompted me to invest in Identillect Techn.
Look at the financial report on 29 august, 2017. Conversion prices now are at $.15 and $.40 (canad. dollarz).
Read the filings.
Who will be the next partner who enters into a contract for Delivery Trust ?
Identillect website
Next financial update end of november.
If next quarter shows a significant increase in revenue, prices will explode. JIMHO.
$$$ GLTA $$$
I am buying more, the short-sighted lumberjacks still don't know, what they have on their stock market. Gnaah
Warrants at $.10 are through, now heading for higher placements.
This will go up immediately, if financing will take place over new partner, imho. Next Warrants at $.15.
Microsoft Office 365 resellers will grap the rope, which ID threw into the wide open.
Buyers will pop up soon...
Sales growing faster now ! Are there even more partners in schedule ?
CISOSHARE Partners with Identillect to Broaden its Security Services by Helping Organizations Combat Email-Borne Cyber-attacks
Break-through, definitely. This could boost share price to $ .20.
$$$ Geez! $$$.
CISOSHARE partners with Identillect
Shorties flat ? There was time enough...
Get ready for the next stage of MBRX. Your accumulation finished ? Don't forget about free-float and last two days of stockmoves...1+1=2.
$$$ GLTA $$$
The stocktwits kids talking nonsense again. LMAO.
Accumulation. My dad is still buying...stocktwits kids are not. They are selling. Geeez.
$$$ GLTA $$$
Shorts better leave TODAY.
BIG GAINER ! This will rocket today (again). MD Anderson C.C. is good for potential investors, too. $$$GLTA$$$
Fasten seat belts.
Moleculin Signs Agreement with MD Anderson Cancer Center for Leukemia Drug, Annamycin
This crap is NT 10-Q AND NT 10-K overdue.
SEC will get them busted soon, believe me.
Don't forget about 2013/2014. The share price broke in and that was directly reflected in the debt conversion scale.
Only information brought us up again. What for? To crash again? Waaah ! R/S next imte ?
Worthless news. Hopeful news tell of a marketable product or at least of bigger-scale results in development.
Nothing like that over the past years. This is crap. And you know that.
Look at the hydrogen project sites all over the world. You will find a lot of information on the funding of hydrogen projects. But is hysr there? I have found nothing.
The operating losses and comprehensive losses for the year ended December 31, 2016 were $86,494,893 and $82,397,922 respectively, or $1.28 basic and diluted loss per share, as compared with losses of $26,730,490 and $35,116,695, or $0.41 basic and diluted loss per share for the same period in 2015.
Big loss on last quarter bill
A near death experience called Neovasc.
Coverage. Short time after recommendation by Blair & Company. $$$ GLTA $$$
Coverage Blair & Company from january - read this
$$$ BUY RECOMM AT $ 40 $$$
ALBO buy recommendation at $ 40 - read this
Albireo Pharma (ALBO) was Initiated by Ladenburg Thalmann to “Buy” and the brokerage firm has set the Price Target at $40. Ladenburg Thalmann advised their Clients and Investors in a research report released on Feb 16, 2017.
Ladenburg Thalmann do not take long to look for an ace of spades, they always have the right cards in their pockets, though.
This will soon go up to an appropriate price, imho. No use to wait for long. $$$ Geeez $$$